Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Xinbelai Biotechnology, also known as Synbiolab, is a synthetic biology company specializing in the development and manufacturing of high-value bio-based products. The company focuses on three primary segments: rare sugars such as D-tagatose and D-psicose, medical aesthetic ingredients like Pro-xylane and Ergothioneine, and specialized peptide drugs including HGH fragments and Bremelanotide. Synbiolab leverages an advanced enzyme engineering and biocatalysis platform to produce pharmaceutical intermediates and active ingredients with high purity and efficiency. Headquartered in China, the company maintains production and R&D facilities in Hunan and Zhejiang, serving a global client base in the pharmaceutical, cosmetic, and functional food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Xinbelai Biotechnology.